GH Research (GHRS)
(Delayed Data from NSDQ)
$12.10 USD
-0.05 (-0.41%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $12.05 -0.05 (-0.41%) 6:12 PM ET
1-Strong Buy of 5 1
D Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
GH Research PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GHRS 12.10 -0.05(-0.41%)
Will GHRS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GHRS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GHRS
Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade
What Makes GH Research (GHRS) a New Buy Stock
GHRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
GHRS Stock Rallies 55% in a Week: Here's What You Should Know
Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect?
GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade
Other News for GHRS
Psychedelic: Cybin receives European approval for EMBRACE study
Psychedelic: Cybin receives European approval for EMBRACE study
GH Research GAAP EPS of -$0.15
GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates | GHRS ...
GH Research reports Q2 EPS (15c), consensus (20c)